Correlation Between Integral and Tandem Diabetes
Can any of the company-specific risk be diversified away by investing in both Integral and Tandem Diabetes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Integral and Tandem Diabetes into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Integral Ad Science and Tandem Diabetes Care, you can compare the effects of market volatilities on Integral and Tandem Diabetes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Integral with a short position of Tandem Diabetes. Check out your portfolio center. Please also check ongoing floating volatility patterns of Integral and Tandem Diabetes.
Diversification Opportunities for Integral and Tandem Diabetes
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Integral and Tandem is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Integral Ad Science and Tandem Diabetes Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tandem Diabetes Care and Integral is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Integral Ad Science are associated (or correlated) with Tandem Diabetes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tandem Diabetes Care has no effect on the direction of Integral i.e., Integral and Tandem Diabetes go up and down completely randomly.
Pair Corralation between Integral and Tandem Diabetes
Considering the 90-day investment horizon Integral is expected to generate 3.9 times less return on investment than Tandem Diabetes. But when comparing it to its historical volatility, Integral Ad Science is 1.39 times less risky than Tandem Diabetes. It trades about 0.01 of its potential returns per unit of risk. Tandem Diabetes Care is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 3,350 in Tandem Diabetes Care on October 9, 2024 and sell it today you would earn a total of 355.00 from holding Tandem Diabetes Care or generate 10.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Integral Ad Science vs. Tandem Diabetes Care
Performance |
Timeline |
Integral Ad Science |
Tandem Diabetes Care |
Integral and Tandem Diabetes Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Integral and Tandem Diabetes
The main advantage of trading using opposite Integral and Tandem Diabetes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Integral position performs unexpectedly, Tandem Diabetes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tandem Diabetes will offset losses from the drop in Tandem Diabetes' long position.The idea behind Integral Ad Science and Tandem Diabetes Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Tandem Diabetes vs. DexCom Inc | Tandem Diabetes vs. Inspire Medical Systems | Tandem Diabetes vs. Penumbra | Tandem Diabetes vs. Insulet |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |